ArticleCureus2026
Comparison of 0.1% Ropivacaine and 0.0625% Bupivacaine With Fentanyl as an Adjuvant for Labour Analgesia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims Effective pain relief during labour is an important component of obstetric care, with epidural analgesia being the most reliable method. Using low concentrations of local anaesthetics combined with opioids can provide adequate analgesia while minimizing adverse effects. In this study, we compared the analgesic effectiveness of 0.1% ropivacaine and 0.0625% bupivacaine, each administered with fentanyl (2 mcg/mL), for epidural labour analgesia. Methods A double-blinded randomized controlled study was conducted with 40 parturients belonging to ASA physical status I or II. They were divided into two groups of 20 each by computer-generated block randomization. Group A received bolus doses of 0.0625% bupivacaine with 2 mcg/mL fentanyl. Group B received bolus doses of 0.1% ropivacaine with 2 mcg/mL fentanyl. The outcomes assessed included hemodynamic stability, sensory blockade, motor blockade, pain score using a visual analogue scale (VAS), number of supplemental doses, total drug consumption, first and second stages of labour duration, mode of delivery, maternal satisfaction, outcomes of the newborn, and adverse effects such as hypotension, bradycardia, nausea, and vomiting. Results The sensory blockade onset was significantly faster in Group A compared to Group B (p = 0.03). VAS scores were significantly lower in Group A at 5 minutes (p < 0.0001), 10 minutes (p = 0.0003), 15 minutes (p = 0.02), 1 hour (p < 0.001), and 2 hours (p = 0.0002). Group A also required fewer additional doses and demonstrated lower overall drug consumption (p = 0.02). Maternal satisfaction scores were significantly higher in Group A (p = 0.01). Conclusion Epidural labour analgesia with 0.0625% bupivacaine with fentanyl (2 mcg/mL) provides superior analgesic efficacy, faster onset, and reduced drug requirements compared to 0.1% ropivacaine with fentanyl (2 mcg/mL), while maintaining a comparable safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.